HonorHealth
Phoenix, Arizona, United States, 85016
Contact: Kristin Vaona   602-253-5300   KriVaona@honorshealth.com  Â
Principal Investigator: Bradley Monk      Â
Arizona Oncology Associates SC
Phoenix, Arizona, United States, 85710
Contact: Ramona Medina   520-886-0206   ramona.medina@usoncology.com  Â
Principal Investigator: Joseph Buscema      Â
Highlands Oncology Group Main
Fayetteville, Arkansas, United States, 72703
Contact: Heather Campbell   479-872-8130   hcampbell@hogonc.com  Â
Principal Investigator: J. Thaddeus Beck      Â
Stanford Cancer Center
Stanford, California, United States, 94305
Contact: Samya Konda   650-723-0594   skonda@stanford.edu  Â
Principal Investigator: Oliver Dorigo      Â
Florida Cancer Specialists Dept of Oncology (2)
Fort Myers, Florida, United States, 33901
Contact: Lyrae Layne   727-216-1143   lyrae.layne@flcancer.com  Â
Principal Investigator: Jennifer L Cultrera      Â
Florida Cancer Specialists
Fort Myers, Florida, United States, 33901
Contact: Lisa Bruns   239-274-9930   lisa.Bruns@flcancer.com  Â
Principal Investigator: Elizabeth Guancial      Â
Florida Cancer Specialists Panhandle
Tallahassee, Florida, United States, 32308
Contact: Sheila Gagne   615-329-7482   sheila.gagne@flcancer.com  Â
Principal Investigator: Margarett Ellison      Â
Florida Cancer Specialists
West Palm Beach, Florida, United States, 33401
Contact: Gabrielle Jasmin   561-366-4149   gabrielle.jasmin@flcancer.com  Â
Principal Investigator: Todd Gersten      Â
Illinois Cancer Specialists
Arlington Heights, Illinois, United States, 60005
Contact   847-259-4482    Â
Principal Investigator: Urszula Sobol      Â
Maryland Oncology Hematology P A
Silver Spring, Maryland, United States, 20904
Contact: Madi Gaudieri   999-999-9999   madi.gaudieri@usoncology.com  Â
Principal Investigator: Frederick Min      Â
Massachusetts General Hospital Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Contact: Hilda Guitierrez     hlgutierrez@mgh.harvard.edu  Â
Principal Investigator: Sara Bouberhan      Â
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
Contact: Eliana Ellenberger   617-632-5136   Eliana_Ellenberger@DFCI.HARVARD.EDU  Â
Principal Investigator: Panagiotis Konstantinopoulos      Â
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Contact: Jade Cohen     cohenj5@mskcc.org  Â
Principal Investigator: Rachel Grisham      Â
Oncology Hematology Care Inc
Cincinnati, Ohio, United States, 45242
Contact: Alessandra Hubbell     alessa.hubbell@usoncology.com  Â
Principal Investigator: Ajit Coo Gubbi      Â
University of Cincinnati Dept of Oncology
Cincinnati, Ohio, United States, 45267
Contact: Gena Burns   513-584-0429   burnsga@ucmail.uc.edu  Â
Principal Investigator: Thomas Herzog      Â
Avera Cancer Institute
Sioux Falls, South Dakota, United States, 57106
Contact: Teri Kayl   605-322-3000   Teri.Kayl@avera.org  Â
Principal Investigator: David Starks      Â
Sarah Cannon Research Institute
Nashville, Tennessee, United States, 37203
Contact: Jeremy Gilbert   +1 615 340 1515   jeremy.gilbert@sarahcannon.com  Â
Principal Investigator: Erika Paige Hamilton      Â
Texas Oncology, P.A. Texas Oncology – South Austin
Bedford, Texas, United States, 76022
Contact: Sara Manning   512-912-2761   sara.manning@usoncology.com  Â
Principal Investigator: Michael Teneriello      Â
Texas Oncology Charles A. Sammons Cancer Ctr
Dallas, Texas, United States, 75246
Contact: Julie Morehouse     Julie.morehouse@usoncology.com  Â
Principal Investigator: Brandon T Sawyer      Â
Texas Oncology P A
San Antonio, Texas, United States, 78217
Contact: Debbie A Ponce     debbie.ponce@usoncology.com  Â
Principal Investigator: Antonio Santillan-Gomez      Â
Texas Oncology Northeast Texas
Tyler, Texas, United States, 75702
Contact: Shelly Maxfield   903-579-9867   shelly.maxfield@usoncology.com  Â
Principal Investigator: Anna Priebe      Â
Novartis Investigative Site
Caba, Buenos Aires, Argentina, C1056ABJ
Novartis Investigative Site
Caba, Buenos Aires, Argentina, C1125ABD
Novartis Investigative Site
Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1015ABO
Novartis Investigative Site
Rosario, Santa Fe, Argentina, S2002
Novartis Investigative Site
Buenos Aires, Argentina, C1012AAR
Novartis Investigative Site
Randwick, New South Wales, Australia, 2031
Novartis Investigative Site
Bedford Park, South Australia, Australia, 5041
Novartis Investigative Site
Shepparton, Victoria, Australia, 3630
Novartis Investigative Site
Innsbruck, Tyrol, Austria, 6020
Novartis Investigative Site
Graz, Austria, 8036
Novartis Investigative Site
Bruxelles, Belgium, 1000
Novartis Investigative Site
Leuven, Belgium, 3000
Novartis Investigative Site
Namur, Belgium, 5000
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil, 30130-100
Novartis Investigative Site
Sao Paulo, SP, Brazil, 01317-002
Novartis Investigative Site
Sao Paulo, SP, Brazil, 04014-002
Novartis Investigative Site
Calgary, Alberta, Canada, T2N 4N2
Novartis Investigative Site
Vancouver, British Columbia, Canada, V5Z 4E6
Novartis Investigative Site
London, Ontario, Canada, N6A 5W9
Novartis Investigative Site
Toronto, Ontario, Canada, M4N 3M5
Novartis Investigative Site
Shantou, Guangdong, China, 515041
Novartis Investigative Site
Harbin, Heilongjiang, China, 150081
Novartis Investigative Site
Changsha, Hunan, China, 410013
Novartis Investigative Site
Chengdu, Sichuan, China, 610041
Novartis Investigative Site
Tianjin, Tianjin, China, 300060
Novartis Investigative Site
Beijing, China, 100036
Novartis Investigative Site
Jinan, China, 250012
Novartis Investigative Site
Shanghai, China, 200032
Novartis Investigative Site
Wuhan, China, 430022
Novartis Investigative Site
Xi’an, China
Novartis Investigative Site
Novy Jicin, Czech Republic, Czechia, 74101
Novartis Investigative Site
Brno, Czechia, 62500
Novartis Investigative Site
Ostrava Poruba, Czechia, 708 52
Novartis Investigative Site
Praha 2, Czechia, 128 51
Novartis Investigative Site
Herlev, Denmark, 2730
Novartis Investigative Site
Odense C, Denmark, DK 5000
Novartis Investigative Site
Kuopio, Finland, FIN-70211
Novartis Investigative Site
Oulu, Finland, FIN-90220
Novartis Investigative Site
Tampere, Finland, FIN-33521
Novartis Investigative Site
Turku, Finland, FIN-20521
Novartis Investigative Site
Besancon cedex, France, 25030
Novartis Investigative Site
Lyon Cedex, France, 69373
Novartis Investigative Site
Paris, France, 75012
Novartis Investigative Site
Pierre Benite Cedex, France, 69495
Novartis Investigative Site
Villejuif Cedex, France, 94800
Novartis Investigative Site
Mannheim, Baden-Wuerttemberg, Germany, 68305
Novartis Investigative Site
Berlin, Germany, 13353
Novartis Investigative Site
Dresden, Germany, 01307
Novartis Investigative Site
Essen, Germany, 45136
Novartis Investigative Site
Essen, Germany, 45147
Novartis Investigative Site
Mainz, Germany, 55131
Novartis Investigative Site
Bologna, BO, Italy, 40138
Novartis Investigative Site
Firenze, FI, Italy, 50134
Novartis Investigative Site
Milano, MI, Italy, 20133
Novartis Investigative Site
Milano, MI, Italy, 20141
Novartis Investigative Site
Roma, RM, Italy, 8-00168
Novartis Investigative Site
Vicenza, VI, Italy, 36100
Novartis Investigative Site
Napoli, Italy, 80131
Novartis Investigative Site
Seoul, Korea, Republic of, 03080
Novartis Investigative Site
Seoul, Korea, Republic of, 03722
Novartis Investigative Site
Kota Kinabalu, Sabah, Malaysia, 88996
Novartis Investigative Site
Kuching, Sarawak, Malaysia, 93586
Novartis Investigative Site
Kuala Lumpur, Wilayah Persekutuan, Malaysia, 50586
Novartis Investigative Site
Kuala Lumpur, Malaysia, 59100
Novartis Investigative Site
Monterrey, Nuevo Leon, Mexico, 64460
Novartis Investigative Site
Culiacan, Sinaloa, Mexico, 80040
Novartis Investigative Site
Ciudad de Mexico, Mexico, 04700
Novartis Investigative Site
Eindhoven, Netherlands, 5623 EJ
Novartis Investigative Site
Leiden, Netherlands, 2333 ZA
Novartis Investigative Site
Lisbon, Portugal, 1400 038
Novartis Investigative Site
Loures, Portugal, 2674514
Novartis Investigative Site
Porto, Portugal, 4200-072
Novartis Investigative Site
Arkhangelsk, Russian Federation, 163045
Novartis Investigative Site
Ufa, Russian Federation, 450054
Novartis Investigative Site
Singapore, Singapore, 119228
Novartis Investigative Site
Singapore, Singapore, 169610
Novartis Investigative Site
Bratislava, Slovakia, 83310
Novartis Investigative Site
Trencin, Slovakia, 91171
Novartis Investigative Site
Cordoba, Andalucia, Spain, 14004
Novartis Investigative Site
Barcelona, Catalunya, Spain, 08035
Novartis Investigative Site
Barcelona, Catalunya, Spain, 08036
Novartis Investigative Site
Valencia, Comunidad Valenciana, Spain, 46010
Novartis Investigative Site
Pamplona, Navarra, Spain, 31008
Novartis Investigative Site
Madrid, Spain, 28034
Novartis Investigative Site
Taichung, Taiwan, 40705
Novartis Investigative Site
Taipei, Taiwan, 10002
Novartis Investigative Site
Taipei, Taiwan, 11217
Novartis Investigative Site
Adana, Turkey, 01160
Novartis Investigative Site
Ankara, Turkey, 06100
Novartis Investigative Site
Ankara, Turkey, 06520
Novartis Investigative Site
Istanbul, Turkey, 34214
Novartis Investigative Site
Izmir, Turkey
Novartis Investigative Site
Trabzon, Turkey, 61080
Novartis Investigative Site
Glasgow, United Kingdom, G12 0YN
Novartis Investigative Site
London, United Kingdom, SE1 9RT
Novartis Investigative Site
Manchester, United Kingdom, M20 4BX
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
